Back

1995S-0316
RPT 361
Volume 270

Cover Page

Letter from CFSAN to The Center for Lifestyle Disease

FDA Pre Market Notification for "Absolbotani"

Attachment A-1 Chemical Identification of Absolbotani: Mass Balance Test Redacted/Published Material

Center for the Evaluation of Risks to Human Reproduction (CERHR) Expert Panels Restricted Pages

Attachment B-1 Toxicity Studies - on Absolbotani, referenced herein as Absolute Fx Liquid

Attachment C-1 Office of Nutritional Products, Labeling and Dietary Supplements request for special allowance for Trade Secret Protected, Absolbotani, a proprietary botanical extract.

Letter from The Center for Lifestyle Disease to CFSAN

Addendum Pre Market Notification for "Absoibotani"

Top | Back

Page last updated May 1, 2007 RSC
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management